Jane Chang

Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma

Petros Grivas, Evgeny Kopyltsov, Po‐Jung Su et al. · European Urology · 2022 · 54 citations · Full text

Medicine, Oncology, Urology +13

Treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer initiating first-line treatment in the US community oncology setting: a real-world retrospective observational study

Eric Nadler, Bhakti Arondekar, Kathleen M. Aguilar et al. · Journal of Cancer Research and Clinical Oncology · 2020 · 43 citations · Full text

Medicine, Oncology, Chemotherapy +15

The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States

Dominick Latrémouille-Viau, Jane Chang, Annie Guérin et al. · Journal of Medical Economics · 2016 · 21 citations

Medicine, Oncology, Pharmacoeconomics +17

Treatment Patterns and Health Outcomes in Platinum-Refractory or Platinum-Resistant Ovarian Cancer

Rohan Parikh, Samantha K. Kurosky, James A. Kaye et al. · International Journal of Gynecological Cancer · 2018 · 20 citations

Medicine, Surgery, Cancer Epidemiology +16

Economic Impact of Bladder Cancer in the USA

O Clark, Tulio Sarmento, Anthony Eccleston et al. · PharmacoEconomics - Open · 2024 · 19 citations · Full text

Medicine, Oncology, Urology +17